# Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies

> **NCT03779074** · PHASE3 · COMPLETED · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 918 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** 10d bismuth quadruple therapy
- **DRUG:** 14d hybrid therapy
- **DRUG:** 14D high-dose dual therapy

## Key facts

- **NCT ID:** NCT03779074
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-03
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 918 (ACTUAL)
- **Last updated:** 2023-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03779074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03779074, "Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03779074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*